Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Reviews on Recent Clinical Trials|October 25, 2012
Randomized controlled trials in steroid dependent and in severe colitisMaria Lia Scribano, Laura Cantoro, Luigi Giovanni Papparella, et al.Journal of Clinical Gastroenterology|March 27, 2014
Mucosal healing with thalidomide in refractory Crohn's disease patients intolerant of anti-TNF-α drugs: report of 3 cases and literature reviewMaria Lia Scribano, Laura Cantoro, Marzia Marrollo, et al.United European Gastroenterology Journal|March 28, 2020
Early-onset versus late-onset Crohn's disease: An Italian cohort studyLaura Cantoro, Marco Vincenzo Lenti, Rita Monterubbianesi, et al.Diagnostics (Basel, Switzerland)|October 28, 2023
The Earlier You Find, the Better You Treat: Red Flags for Early Diagnosis of Inflammatory Bowel DiseaseLaura Cantoro, Rita Monterubbianesi, Giuliano Falasco, et al.Clinical Rheumatology|May 16, 2014
The role of interferon-gamma release assays in predicting the emergence of active tuberculosis in the setting of biological treatment: a case report and review of the literatureRossana Scrivo, Ilaria Sauzullo, Fabio Mengoni, et al.Inflammatory Bowel Diseases|February 2, 2008
Splenic function and IgM-memory B cells in Crohn's disease patients treated with infliximabAntonio Di Sabatino, M Manuela Rosado, Paolo Cazzola, et al.Journal of Crohn'S & Colitis|March 24, 2017
The Time Course of Diagnostic Delay in Inflammatory Bowel Disease Over the Last Sixty Years: An Italian Multicentre StudyLaura Cantoro, Antonio Di Sabatino, Claudio Papi, et al.American Journal of Clinical Pathology|June 14, 2008
Distribution, proliferation, and function of Paneth cells in uncomplicated and complicated adult celiac diseaseAntonio Di Sabatino, Emanuela Miceli, Winnie Dhaliwal, et al.Journal of Crohn'S & Colitis|June 4, 2018
Therapeutic Drug Monitoring is More Cost-Effective than a Clinically Based Approach in the Management of Loss of Response to Infliximab in Inflammatory Bowel Disease: An Observational Multicentre StudyLuisa Guidi, Daniela Pugliese, Tommaso Panici Tonucci, et al.Inflammatory Bowel Diseases|January 17, 2017
The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab BiosimilarGionata Fiorino, Natalia Manetti, Alessandro Armuzzi, et al.Pageof 2